Is the Surge in Ampio Sustainable?
Ampio Pharmaceuticals made waves in the market on Tuesday morning and it looked like a day trader’s dream.
All Work
Chris Lange
Carnival Slips on Guidance
Carnival released better-than-expected quarterly results before the markets opened on Tuesday.
Why CarMax’s Record Q2 Earnings Were Not Enough
CarMax reported mixed fiscal second-quarter financial results before the markets open on Tuesday morning.
Red Hat Posts Solid Beat on Earnings
ThinkstockRed Hat, Inc. (NYSE: RHT) reported its fiscal second quarter financial results after the markets closed on Tuesday. The company had $0.47 in earnings per share (EPS) on $504 million in revenue compared to…
Is the Move in Plug Power Sustainable?
Plug Power has been a roller-coaster stock. Within the past 18 months it has traded around $10 and around $1.50.
Why at Least One Analyst Isn’t Chasing Neogen
Neogen reported disappointing fiscal first-quarter financial results before the markets opened on Monday morning.
Atlanta Fed President Speaks on Fed’s Decision to Hold Off
ThinkstockAtlanta Fed President and CEO Dennis Lockhart issued a speech to the Buckhead Rotary Club in which he discussed current economic conditions and the recent Federal Open Market Committee (FOMC) decision to hold off…
What to Expect From Carnival Earnings
Carnival is scheduled to report its fiscal third-quarter financial results before the markets open on Tuesday.
What to Expect From CarMax Earnings
CarMax is scheduled to report is fiscal second-quarter financial results before the markets on Tuesday.
Chinese Solar Stocks Set to Rise With Eyes on US Settlement
In the past week, Credit Suisse held over a dozen meetings with solar companies across the value chain at its annual Renewables Roundup event.
Did NRG Energy Just Become a Screaming Buy?
ThinkstockNRG Energy Inc. (NYSE: NRG) hit a new 52-week low in Monday’s trading session. Now, many could argue that investors should have been abandoning ship on the long way down. However, one key analyst…
What to Expect From Red Hat Earnings
Red Hat is scheduled to report its fiscal second-quarter financial results after the markets close on Monday.
Edge Therapeutics Closes in on IPO With Updated Terms
Edge Therapeutics is offering more than 5 million shares in its initial public offering in an expected price range of $14 to $16 apiece.
Why Apple Gets Higher Market Share and a Higher Analyst Price Target
Canaccord Genuity reiterated a Buy rating on Apple and raised its price target, implying an upside of 40% from current prices.
NovoCure Gears Up for IPO
NovoCure has made an updated filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Dave & Buster’s Prepares for Secondary Offering
Dave & Buster's Entertainment has filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering of 6 million shares.
Are Atmel Shareholders Getting Enough in the Buyout?
Over the weekend, Dialogue Semiconductor announced that it had entered into an agreement to acquire Atmel to the tune of roughly $4.6 billion.
Top 5 Earnings for the Week Ahead
Thinkstock24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We have included the consensus earnings estimates from Thomson Reuters and the stock price…
Top 6 Biotech Movers From the Past Week
ThinkstockOver the past week, a few biotech companies made absolutely massive runs and some had serious falls. In the past year, the health care sector was on fire from positive trials, U.S. Food and…
Vascular Biogenics Rises on Presentation Hype
Vascular Biogenics was one of the leading stocks in the health care sector Friday, following news that the company will present at the European Society for Medical Oncology (ESMO) European Cancer Congress 2015.